OZURDEX (dexamethasone)
OPHTHALMIC STEROIDS·BRANCH RETINAL VEIN OCCLUSION WITH MACULAR EDEMA·+3
Allergan
Indication
Diabetic macular edema
Diabetic macular edema is a vision-threatening manifestation of diabetic retinopathy characterized by the accumulation of excess extracellular fluid and subsequent thickening of the macula, the retinal region responsible for sharp, high-acuity central vision. Read more about Diabetic macular edema
16 drugs 12 manufacturers
Drugs that treat it
Common Diabetic macular edema therapies.
EYLEA (aflibercept)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·DIABETIC RETINOPATHY·+4
Regeneron Pharmaceuticals, Inc.
ILUVIEN (fluocinolone acetonide)
OPHTHALMIC STEROIDS·NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF EYE·+1
ALIMERA SCIENCE
LUCENTIS (ranibizumab)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·DIABETIC RETINOPATHY·+5
GENENTECH
BEOVU (brolucizumab-dbll)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·NEOVASCULAR AGE-RELATED MACULAR DEGENERATION·+1
Novartis Pharmaceuticals
SUSVIMO (ranibizumab)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·DIABETIC RETINOPATHY·+2
GENENTECH
VABYSMO (faricimab-svoa)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·NEOVASCULAR AGE-RELATED MACULAR DEGENERATION·+2
GENENTECH
CIMERLI (ranibizumab-eqrn)
DIABETIC RETINOPATHY·+5
COHERUS BIOSCIE
EYLEA HD (aflibercept)
OPHTHALMIC - MACULAR DEGENERATION AGENTS·DIABETIC RETINOPATHY·+3
Regeneron Pharmaceuticals, Inc.
Filter & compare in the drug finder →Opens the drug finder with Diabetic macular edema preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetic macular edema is a vision-threatening manifestation of diabetic retinopathy characterized by the accumulation of excess extracellular fluid and subsequent thickening of the macula, the retinal region responsible for sharp, high-acuity central vision.
Affecting individuals with chronic diabetes mellitus, the condition arises from sustained hyperglycemia, microvascular damage, and increased vascular permeability mediated by inflammatory cytokines and vascular endothelial growth factor.
This pathophysiologic cascade leads to breakdown of the blood-retinal barrier and intraretinal fluid leakage.
Clinically, it manifests as progressive visual acuity loss, central blurriness, and visual distortion, representing a primary cause of moderate-to-severe visual impairment in the diabetic population.
- nih.gov
Diabetic macular edema is a vision-threatening manifestation of diabetic retinopathy characterized by the accumulation of excess extracellular fluid and subsequent thickening of the macula, the retinal region responsible for sharp, high-acuity central vision Affecting individuals with chronic diabetes mellitus, the condition arises from sustained hyperglycemia, microvascular damage, and increased vascular permeability mediated by inflammatory cytokines and vascular endothelial growth factor
- nih.gov
Diabetic macular edema is a vision-threatening manifestation of diabetic retinopathy characterized by the accumulation of excess extracellular fluid and subsequent thickening of the macula, the retinal region responsible for sharp, high-acuity central vision Affecting individuals with chronic diabetes mellitus, the condition arises from sustained hyperglycemia, microvascular damage, and increased vascular permeability mediated by inflammatory cytokines and vascular endothelial growth factor This...
- nih.gov
Diabetic macular edema is a vision-threatening manifestation of diabetic retinopathy characterized by the accumulation of excess extracellular fluid and subsequent thickening of the macula, the retinal region responsible for sharp, high-acuity central vision Affecting individuals with chronic diabetes mellitus, the condition arises from sustained hyperglycemia, microvascular damage, and increased vascular permeability mediated by inflammatory cytokines and vascular endothelial growth factor This...
- nih.gov
Clinically, it manifests as progressive visual acuity loss, central blurriness, and visual distortion, representing a primary cause of moderate-to-severe visual impairment in the diabetic population
- nih.gov
Clinically, it manifests as progressive visual acuity loss, central blurriness, and visual distortion, representing a primary cause of moderate-to-severe visual impairment in the diabetic population
Personalize your experience
Follow Diabetic macular edema and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.